Biotech · Private company
F2G Biotech GmbH
Track this companyFree. Adds F2G Biotech GmbH to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- OlorofimPhase 2 · Invasive Fungal InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- OlorofimPhase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- OlorofimPhase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Olorofim in Early Coccidioidal MeningitisPHASE2 · RECRUITING · started Jun 1, 2026ClinicalTrials.gov NCT07385638 · fetched Nov 12, 2026
- A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal ImpairmentPHASE1 · COMPLETED · started Feb 10, 2022ClinicalTrials.gov NCT05200286 · fetched Nov 12, 2026
- A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic ImpairmentPHASE1 · COMPLETED · started Jul 2, 2021ClinicalTrials.gov NCT04752540 · fetched Nov 12, 2026
- Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment OptionsPHASE2 · COMPLETED · started Jun 6, 2018ClinicalTrials.gov NCT03583164 · fetched Nov 12, 2026